ZIRANU, PINA
 Distribuzione geografica
Continente #
EU - Europa 32.340
NA - Nord America 1.659
AS - Asia 948
SA - Sud America 179
AF - Africa 30
Totale 35.156
Nazione #
IT - Italia 31.840
US - Stati Uniti d'America 1.605
SG - Singapore 442
CN - Cina 272
SE - Svezia 147
BR - Brasile 145
VN - Vietnam 95
DE - Germania 79
GB - Regno Unito 57
FR - Francia 45
FI - Finlandia 36
IN - India 34
CA - Canada 27
NL - Olanda 25
HK - Hong Kong 23
ES - Italia 20
MX - Messico 20
IE - Irlanda 17
PL - Polonia 16
KR - Corea 15
AT - Austria 13
UA - Ucraina 12
EC - Ecuador 11
ZA - Sudafrica 9
AR - Argentina 8
BE - Belgio 8
IQ - Iraq 8
JP - Giappone 7
MA - Marocco 7
RU - Federazione Russa 7
IR - Iran 6
TR - Turchia 6
BD - Bangladesh 5
VE - Venezuela 5
PK - Pakistan 4
BZ - Belize 3
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MU - Mauritius 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 35.156
Città #
Cagliari 30.443
Uta 1.181
Ashburn 267
Dallas 229
Singapore 215
Fairfield 100
Boardman 93
Nyköping 83
Beijing 82
Chandler 78
New York 57
Los Angeles 56
Houston 53
Seattle 51
Wilmington 42
Woodbridge 40
Santa Clara 35
Ho Chi Minh City 33
Cambridge 31
Rome 29
The Dalles 26
Boston 23
Helsinki 23
Hong Kong 23
Shanghai 22
Hefei 20
Amsterdam 19
Redondo Beach 17
Dearborn 16
Frankfurt am Main 16
London 16
Nuremberg 16
Hanoi 15
Munich 15
Seoul 15
Buffalo 14
Toronto 13
Warsaw 13
Chicago 12
Dong Ket 12
Dublin 11
Düsseldorf 11
Poplar 11
Pune 11
Ann Arbor 10
Milan 10
Montreal 10
Guangzhou 9
Jacksonville 9
San Diego 9
São Paulo 9
Brooklyn 8
Chennai 8
Denver 8
Mexico City 8
Stockholm 8
Johannesburg 7
Lappeenranta 7
Paris 7
Rio de Janeiro 7
Selargius 7
Casablanca 6
Salt Lake City 6
Wuhan 6
Baghdad 5
Bexley 5
Biên Hòa 5
Boulder 5
Centro 5
Menlo Park 5
Nanjing 5
New Delhi 5
Olbia 5
Phoenix 5
Quito 5
Shenzhen 5
Tokyo 5
Turku 5
Vienna 5
Augusta 4
Belo Horizonte 4
Brussels 4
Campinas 4
Charlotte 4
Guayaquil 4
Haiphong 4
La Maddalena 4
Maceió 4
Manchester 4
Naples 4
Orem 4
Querétaro 4
Sestu 4
Tehran 4
Zhengzhou 4
Atlanta 3
Belize City 3
Bishkek 3
Buenos Aires 3
Fortaleza 3
Totale 33.901
Nome #
Clustered protocadherins methylation alterations in cancer 3.278
BRAF-mutant colorectal cancer, a different breed evolving 3.212
Molecular-biology-driven treatment for metastatic colorectal cancer 2.718
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.640
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.327
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.122
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.098
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study 1.827
Immunotherapy and Cancer: The Multi-Omics Perspective 1.557
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.491
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.184
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 1.009
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 946
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 905
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 903
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 744
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 715
Uncovering key targets of success for immunotherapy in pancreatic cancer 680
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 670
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 621
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 531
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 472
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 405
CD44: A New Prognostic Marker in Colorectal Cancer? 212
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 198
A new prognostic score for biliary tract cancer: a multicenter experience 194
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 175
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 154
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 151
Medical management of malignant bowel obstruction: our center experience 151
Early taxane exposure and neurotoxicity in breast cancer patients 150
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 148
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 134
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 69
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 67
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 59
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 57
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 55
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 53
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 53
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 51
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 47
The role of metastasectomy in patients with early onset metastatic colorectal cancer 45
Totale 35.278
Categoria #
all - tutte 48.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.959 0 0 0 0 0 864 351 494 204 426 385 235
2021/20222.350 196 120 63 131 142 126 101 128 218 252 312 561
2022/20233.974 319 654 564 307 286 357 175 306 275 290 290 151
2023/20245.431 233 115 136 192 296 560 565 2.165 169 229 374 397
2024/202510.559 3.026 3.284 1.030 1.034 484 701 448 51 122 109 76 194
2025/20261.925 329 255 372 376 300 293 0 0 0 0 0 0
Totale 35.278